Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism JAK1 inhibitors(Tyrosine-protein kinase JAK1 inhibitors), NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), STAT1 inhibitors(Signal transducer and activator of transcription 1-alpha/beta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammation | Preclinical | China | 01 Oct 2025 |





